Yarrow Bioscience is a New Haven biopharmaceutical company developing drugs for inflammatory and immune conditions. It last closed at $15.79 on Nov 6, up 16.10% on the day.
Only 1 firm rated YARW in the past 90 days, not enough for a consensus
Average 12-month target
$60.00
▲ 280.0% upside
Based on 1 analyst who set a price target on YARW in the past 90 days. The average target is $60.00, with a high of $60.00 and a low of $60.00, compared with the last close of $15.79.
Low $60.00Avg $60.00High $60.00
Blue marker: last close $15.79
Highest target$60.00
Average target$60.00
Lowest target$60.00
Latest rating changes
GuggenheimInitiated
Nov 6Buy$60
BTIGInitiated
Aug 3Buy$58
Date
Firm
Action
Rating
Price target
Nov 6
Guggenheim
Initiated
Buy
$60
Aug 3
BTIG
Initiated
Buy
$58
Loading…
Technical Analysis
YARW · as of the Nov 6 close · updated after every close
Downtrend, nearing oversold
The stock is 19% below its 20 day and 48% below its 50 day average. It is 93% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 36), near oversold. The nearest support is the Pivot at $15.12, and the nearest resistance the Pivot R1 at $16.61.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 14.2%/day
Key levels
$46.9552 week high+197.3%
$30.46200 day average+92.9%
$29.90100 day average+89.4%
$23.3450 day average+47.8%
$20.49Swing high (Oct 20)+29.8%
$18.7520 day average+18.7%
$16.61Pivot R1+5.2%
$15.79Last close
$15.12Pivot−4.2%
$14.29Pivot S1−9.5%
$12.3852 week low−21.6%
Indicators
RSI (14)
35.68
Weak, oversold below 30
Neutral
MACD
-2.11
Below its signal line
Bearish
Stochastic
22.3
Middle of its range
Neutral
ADX (14)
43.5
Strong downtrend
Williams %R
-58.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-198.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.1%
Change over 10 sessions
Bearish
ATR (14)
$2.24
Typical daily range, 14.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 34.9%/day
Key levels
$46.9552 week high+197.3%
$30.46200 day average+92.9%
$29.90100 day average+89.4%
$23.3450 day average+47.8%
$20.49Swing high (Oct 20)+29.8%
$18.7520 day average+18.7%
$16.61Pivot R1+5.2%
$15.79Last close
$15.12Pivot−4.2%
$14.29Pivot S1−9.5%
$12.3852 week low−21.6%
Indicators
RSI (14)
34.18
Weak, oversold below 30
Neutral
MACD
-3.80
Below its signal line
Bearish
Stochastic
7.3
Near the bottom of its range
Oversold
ADX (14)
29.2
Trending down
Williams %R
-89.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-138.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−57.3%
Change over 10 sessions
Bearish
ATR (14)
$5.52
Typical daily range, 34.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for YARW
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how YARW did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow YARW usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How YARW has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
No whale options trades in YARW in the last 90 days.
Total alerts
0
Bullish
0
0%
Bearish
0
0%
Date span
—
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether YARW is in one of them and how their past YARW trades turned out.
Yarrow Bioscience is a biopharmaceutical company based in New Haven, Connecticut, that develops treatments for inflammatory and immune conditions. Its work centers on BET inhibitors, a class of small molecule drugs that aim to calm overactive inflammatory signaling in the body. Its candidates are still in clinical testing and have not been approved for sale. The company's planned focus is on Graves disease and Thyroid Eye Disease, with patients and their treating doctors as the intended users of any approved treatment.
